All Stories

  1. Longitudinal model for a dose-finding study for a rare disease treatment
  2. Statistical Approaches in the Development of Digital Therapeutics
  3. Simulation Practices For Adaptive Trial Designs In Drug And Device Development
  4. Correlated endpoints: simulation, modeling, and extreme correlations
  5. Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies
  6. Optimal Design for Nonlinear Response Models
  7. Approximation of the Fisher Information Matrix for Nonlinear Mixed Effects Models in Population PK/PD Studies
  8. Optimal design for population pk/pd models
  9. PkStaMp Library for Constructing Optimal Population Designs for PK/PD Studies
  10. Pharmacokinetic Studies Described by Stochastic Differential Equations: Optimal Design for Systems with Positive Trajectories
  11. An Adaptive Optimal Design for the E max Model and Its Application in Clinical Trials
  12. Discussion of the “White Paper of the PhRMA PISC Working Group on Adaptive Dose-Ranging Designs”
  13. Population Pharmacokinetic Measures, Their Estimation and Selection of Sampling Times
  14. Practical usage of O'Brien's OLS and GLS statistics in clinical trials
  15. Sample size calculation for the Power Model for dose proportionality studies
  16. Methods of Selecting Informative Variables
  17. Response-Driven Designs in Drug Development
  18. OPTIMAL POPULATION DESIGNS FOR PK MODELS WITH SERIAL SAMPLING
  19. Optimal Designs for Regression Models with Forced Measurements at Baseline
  20. Parameter Estimation for Models with Unknown Parameters in Variance
  21. Component-wise dimension reduction
  22. Design of experiments with unknown parameters in variance
  23. Nonparametric methods for clutter removal
  24. Extracting Information from the Variance Function: Optimal Design
  25. Remarks on extremal problems in nonparametric curve estimation
  26. BAHADUR-TYPE RISKS AND OPTIMAL DESIGNS IN REGRESSION PROBLEMS
  27. Action functional for diffusions in discontinuous media
  28. Action Functional for a Diffusion Process with Discontinuous Drift
  29. Optimal Design of Pharmacokinetic Studies Described by Stochastic Differential Equations